Alexander Morse in Lansdale, Pennsylvania

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Philadelphia College Of Osteopathic Medicine
Graduation Year: 2014
The Primary Medical Specialty for Alexander Morse is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 10
PAC (PECOS ID)#: 9537444997
NPI #: 1912322710
NPI Created On: 03/03/2014
NPI Last Updated Listed as: 07/13/2023
Primary Taxonomy Code: 207RC0000X
License Number:
OS018511
Listed Gender: Male

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
5. Remote evaluations of defibrillator up to 90 days with analysis, review and report
6. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
7. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
9. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
10. New patient office or other outpatient visit, typically 45 minutes
11. New patient office or other outpatient visit, typically 60 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Established patient office or other outpatient, visit typically 40 minutes
14. Initial hospital inpatient care, typically 70 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Critical care delivery critically ill or injured patient, first 30-74 minutes
17. Technetium tc-99m tetrofosmin, diagnostic, per study dose
18. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec
19. Injection, dipyridamole, per 10 mg